Biotechnology and Biomedicine C entre of the Academy of Sciences and C harles University in Vestec

INTRODUCING BIOCEV
Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec

www.biocev.eu

BASIC FACTS

400 researchers 200 students 5 research programmes 54 research teams 5 state of the art core facilities Tech transfer department Integration into the European Research Area
www.biocev.eu

WHO IS BIOCEV

Applicant/recipient
Institute of Molecular Genetics of the ASCR, v. v. i

Partners
Charles University in Prague Institute of Biotechnology of the ASCR, v. v. i. Institute of Physiology of the ASCR, v. v. i. Institute of Microbiology of the ASCR, v. v. i. Institute of Experimental Medicine of the ASCR, v. v. i. Institute of Macromolecular Chemistry of the ASCR, v. v. i.

www.biocev.eu

LOCATION

The centre will be built in the industrial part of Central Bohemian village Vestec, in close vicinity of several biotech companies Total surface area of the modern laboratories - 25,500 sqm Excellent accessibility by both public and private transport Favourable location - close to a major Academy of Sciences biomedical campus

www.biocev.eu

FUNDING

Funded by European Regional Development Fund (through OP RDI) Estimated total project cost: 120 mil. EUR EU Funding: 80 mil. EUR
www.biocev.eu

PRINCIPLES

Three pillars of the knowledge triangle:

Research - synergic research programme, unique top-quality technology in central laboratories Education - development of new, tailor-made study programmes, training of business employees in advanced biotechnology methods Transfer of research results to practice - intensive collaboration with the commercial sphere

www.biocev.eu

RESEARCH

Research Programme
Functional Genomics Cellular Biology and Virology Structural Biology and Protein Engineering Biomaterials and Tissue Engineering Development of Therapeutic and Diagnostic Procedures

Core Facilities
Czech Centre for Phenogenomics Imaging Methods OMICS Centre of Molecular Structure Cryotechnologies

www.biocev.eu

EUROPEAN RESEARCH AREA INTEGRATION

BIOCEV is currently a member of three European infrastructures Infrafrontier, Euro-BioImaging and Instruct All these are part of ESFRI Membership in Elixir is currently under negotiations Integration of these projects under one roof puts BIOCEV into a special position in the context of the Czech research institutions

www.biocev.eu

INFRAFRONTIER

Infrafrontier is the European infrastructure for Phenotyping and Archiving of Model Mammalian Genomes The Goal: to define the function of all mouse genes and in this way model the gene functions in man Infrafrontier brings together partners from twelve European countries and Canada Scientific partners are the leading research facilities in the field of systemic phenotyping, archiving and distribution of mouse models

www.biocev.eu

EURO-BIOIMAGING

Mission: access to state-of-the-art imaging technologies in biomedical sciences service & training & data foster cooperation & innovation share expertise & best practice Preparatory phase 2010 2013
Goal: To develop a construction and operation plan of a large European RI in biological and medical imaging.
www.biocev.eu

CURRENT SCHEDULE

31 October 2011 BIOCEV approved by the European Commission 31 January 2012 BIOCEV approved on the national level (eligible for the European funding) 1Q 2012 launch of the recruitment process for researchers Summer 2012 commencement of technology and equipment purchase April 2013 November 2014 construction phase End of 2014 planned start of the trial operation of BIOCEV 2016 2020 the sustainability phase of the new centre

www.biocev.eu

CONTACTS

Institute of Molecular Genetics of the ASCR, v. v. i. - Division BIOCEV Nad Safinou II 366 252 42 Vestec, Czech Republic Tel.: +420 226 201 526, +420 774 798 102 E-mail: biocev@biocev.eu www.biocev.eu For Applicant /Recipient Prof. Vaclav Horejsi E-mail: horejsi@img.cas.cz Scientific Coordinator Prof. Vaclav Paces E-mail: vpaces@img.cas.cz

www.biocev.eu